Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
KMS Medisurgi Ltd has informed BSE that it is exempt from corporate governance reporting requirements under Regulation 27(2) of SEBI LODR 2015. The company is listed on the BSE SME Platform, which qualifies it for exemption under Regulation 15(2). This exemption applies to regulations 17 through 27 and related clauses of Schedule V. The company stated it is not required to disclose a Report on Corporate Governance for the year ended 31 March 2026. The filing was signed by Managing Director Siddharth Kanakia on 21 April 2026.
As an SME-listed company, KMS Medisurgi operates under relaxed corporate governance norms. Investors should note that detailed CG disclosures required for mainboard listed companies do not apply here, meaning less transparency on board composition, audit committees, and related party transactions.